196 related articles for article (PubMed ID: 28624015)
1. Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy.
Toft J; Hadden WJ; Laurence JM; Lam V; Yuen L; Janssen A; Pleass H
Eur J Radiol; 2017 Jul; 92():17-23. PubMed ID: 28624015
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
[TBL] [Abstract][Full Text] [Related]
3. MRI vs. CT for pancreatic adenocarcinoma vascular invasion: comparative diagnostic test accuracy systematic review and meta-analysis.
Jajodia A; Wang A; Alabousi M; Wilks C; Kulkarni A; van der Pol CB
Eur Radiol; 2023 Oct; 33(10):6883-6891. PubMed ID: 37083741
[TBL] [Abstract][Full Text] [Related]
4. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
5. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
7. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
[TBL] [Abstract][Full Text] [Related]
8. Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature.
Shrikhande SV; Barreto SG; Goel M; Arya S
HPB (Oxford); 2012 Oct; 14(10):658-68. PubMed ID: 22954001
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
10. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods.
Sijithra PC; Santhi N; Ramasamy N
Eur J Radiol; 2023 Sep; 166():110972. PubMed ID: 37454557
[TBL] [Abstract][Full Text] [Related]
11. Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study.
Furtado FS; Ferrone CR; Lee SI; Vangel M; Rosman DA; Weekes C; Qadan M; Fernandez-Del Castillo C; Ryan DP; Blaszkowsky LS; Hong TS; Clark JW; Striar R; Groshar D; Cañamaque LG; Umutlu L; Catalano OA
Mol Imaging Biol; 2021 Jun; 23(3):456-466. PubMed ID: 33415677
[TBL] [Abstract][Full Text] [Related]
12. Role of dual-point 18F-FDG-PET/CT in the diagnosis of pancreatic adenocarcinoma, in patients with and without concomitant chronic pancreatitis: Comparison with CECT and EUS.
Kumar R; Sharma A; Garg P; Sharma R; Datta-Gupta S
Pancreatology; 2021 Jun; 21(4):746-754. PubMed ID: 33632664
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
14. Imaging for pancreatic ductal adenocarcinoma.
Horvat N; Ryan DE; LaGratta MD; Shah PM; Do RK
Chin Clin Oncol; 2017 Dec; 6(6):62. PubMed ID: 29307202
[TBL] [Abstract][Full Text] [Related]
15. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of
Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of MRI for Differentiation of Benign and Malignant Pancreatic Cystic Lesions Compared to CT and Endoscopic Ultrasound: Systematic Review and Meta-analysis.
Udare A; Agarwal M; Alabousi M; McInnes M; Rubino JG; Marcaccio M; van der Pol CB
J Magn Reson Imaging; 2021 Oct; 54(4):1126-1137. PubMed ID: 33847435
[TBL] [Abstract][Full Text] [Related]
18. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma.
Balci NC; Semelka RC
Eur J Radiol; 2001 May; 38(2):105-12. PubMed ID: 11335092
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis.
Yang J; Huang J; Zhang Y; Zeng K; Liao M; Jiang Z; Bao W; Lu Q
Chin Med J (Engl); 2023 Sep; 136(17):2028-2036. PubMed ID: 36728948
[TBL] [Abstract][Full Text] [Related]
20. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Liu Y; Liu M; Liu X; Zhou Y
Abdom Radiol (NY); 2019 Mar; 44(3):950-957. PubMed ID: 30315322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]